Share and Cite
Stenberg, V.Y.; Tornes, A.J.K.; Nilsen, H.R.; Revheim, M.-E.; Bruland, Ø.S.; Larsen, R.H.; Juzeniene, A. Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001. Cancers 2022, 14, 2784. https://doi.org/10.3390/cancers14112784
Stenberg VY, Tornes AJK, Nilsen HR, Revheim M-E, Bruland ØS, Larsen RH, Juzeniene A. Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001. Cancers. 2022; 14(11):2784. https://doi.org/10.3390/cancers14112784
Chicago/Turabian StyleStenberg, Vilde Yuli, Anna Julie Kjøl Tornes, Hogne Røed Nilsen, Mona-Elisabeth Revheim, Øyvind Sverre Bruland, Roy Hartvig Larsen, and Asta Juzeniene. 2022. "Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001" Cancers 14, no. 11: 2784. https://doi.org/10.3390/cancers14112784
APA StyleStenberg, V. Y., Tornes, A. J. K., Nilsen, H. R., Revheim, M.-E., Bruland, Ø. S., Larsen, R. H., & Juzeniene, A. (2022). Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001. Cancers, 14(11), 2784. https://doi.org/10.3390/cancers14112784